DE3685545T2 - System zur transdermalen abgabe von nitroglycerin. - Google Patents
System zur transdermalen abgabe von nitroglycerin.Info
- Publication number
- DE3685545T2 DE3685545T2 DE8686902978T DE3685545T DE3685545T2 DE 3685545 T2 DE3685545 T2 DE 3685545T2 DE 8686902978 T DE8686902978 T DE 8686902978T DE 3685545 T DE3685545 T DE 3685545T DE 3685545 T2 DE3685545 T2 DE 3685545T2
- Authority
- DE
- Germany
- Prior art keywords
- adhesive
- nitroglycerin
- weight
- amount
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 title claims abstract description 86
- 239000000006 Nitroglycerin Substances 0.000 title claims abstract description 86
- 229960003711 glyceryl trinitrate Drugs 0.000 title claims abstract description 86
- 230000037317 transdermal delivery Effects 0.000 title 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims abstract description 21
- 229920000642 polymer Polymers 0.000 claims abstract description 14
- 206010002383 Angina Pectoris Diseases 0.000 claims abstract description 10
- 238000011282 treatment Methods 0.000 claims abstract description 8
- 206010007559 Cardiac failure congestive Diseases 0.000 claims abstract description 6
- 206010019280 Heart failures Diseases 0.000 claims abstract description 6
- 206010020772 Hypertension Diseases 0.000 claims abstract description 4
- 239000000853 adhesive Substances 0.000 claims description 95
- 230000001070 adhesive effect Effects 0.000 claims description 95
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims description 53
- 229920001577 copolymer Polymers 0.000 claims description 36
- 239000000178 monomer Substances 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 26
- 239000011248 coating agent Substances 0.000 claims description 25
- 238000000576 coating method Methods 0.000 claims description 25
- 229940068939 glyceryl monolaurate Drugs 0.000 claims description 25
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims description 19
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims description 19
- 229940093471 ethyl oleate Drugs 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 19
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 18
- DXPPIEDUBFUSEZ-UHFFFAOYSA-N 6-methylheptyl prop-2-enoate Chemical compound CC(C)CCCCCOC(=O)C=C DXPPIEDUBFUSEZ-UHFFFAOYSA-N 0.000 claims description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 125000005233 alkylalcohol group Chemical group 0.000 claims description 5
- 230000002209 hydrophobic effect Effects 0.000 claims description 5
- 125000005397 methacrylic acid ester group Chemical group 0.000 claims description 5
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 4
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 238000011321 prophylaxis Methods 0.000 claims description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 3
- 150000003926 acrylamides Chemical class 0.000 claims description 3
- 230000036772 blood pressure Effects 0.000 claims description 3
- 239000008240 homogeneous mixture Substances 0.000 claims description 3
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims description 3
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical class C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 2
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 claims description 2
- OMNKZBIFPJNNIO-UHFFFAOYSA-N n-(2-methyl-4-oxopentan-2-yl)prop-2-enamide Chemical class CC(=O)CC(C)(C)NC(=O)C=C OMNKZBIFPJNNIO-UHFFFAOYSA-N 0.000 claims description 2
- 230000002035 prolonged effect Effects 0.000 claims description 2
- 230000003014 reinforcing effect Effects 0.000 claims description 2
- 229920001567 vinyl ester resin Chemical class 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical class C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims 1
- 239000010410 layer Substances 0.000 abstract description 15
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 57
- 239000000243 solution Substances 0.000 description 44
- 210000003491 skin Anatomy 0.000 description 38
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- 238000000034 method Methods 0.000 description 19
- 239000000758 substrate Substances 0.000 description 15
- -1 alkyl methacrylates Chemical class 0.000 description 14
- 229940079593 drug Drugs 0.000 description 14
- 239000003814 drug Substances 0.000 description 14
- 239000007787 solid Substances 0.000 description 10
- 230000035515 penetration Effects 0.000 description 9
- 239000011521 glass Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 238000009792 diffusion process Methods 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 5
- 239000012790 adhesive layer Substances 0.000 description 5
- 239000002998 adhesive polymer Substances 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 229920001684 low density polyethylene Polymers 0.000 description 5
- 239000004702 low-density polyethylene Substances 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000004342 Benzoyl peroxide Substances 0.000 description 3
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 239000002390 adhesive tape Substances 0.000 description 3
- 235000019400 benzoyl peroxide Nutrition 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000002964 rayon Substances 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- XLYMOEINVGRTEX-ONEGZZNKSA-N (e)-4-ethoxy-4-oxobut-2-enoic acid Chemical compound CCOC(=O)\C=C\C(O)=O XLYMOEINVGRTEX-ONEGZZNKSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- PGYJSURPYAAOMM-UHFFFAOYSA-N 2-ethenoxy-2-methylpropane Chemical compound CC(C)(C)OC=C PGYJSURPYAAOMM-UHFFFAOYSA-N 0.000 description 1
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- CFVWNXQPGQOHRJ-UHFFFAOYSA-N 2-methylpropyl prop-2-enoate Chemical compound CC(C)COC(=O)C=C CFVWNXQPGQOHRJ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000003522 acrylic cement Substances 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000003163 cell fusion method Methods 0.000 description 1
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical class OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- ZWWQRMFIZFPUAA-UHFFFAOYSA-N dimethyl 2-methylidenebutanedioate Chemical compound COC(=O)CC(=C)C(=O)OC ZWWQRMFIZFPUAA-UHFFFAOYSA-N 0.000 description 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
- GFJVXXWOPWLRNU-UHFFFAOYSA-N ethenyl formate Chemical compound C=COC=O GFJVXXWOPWLRNU-UHFFFAOYSA-N 0.000 description 1
- 125000000816 ethylene group Chemical class [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- MJEMIOXXNCZZFK-UHFFFAOYSA-N ethylone Chemical group CCNC(C)C(=O)C1=CC=C2OCOC2=C1 MJEMIOXXNCZZFK-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- XLYMOEINVGRTEX-UHFFFAOYSA-N fumaric acid monoethyl ester Natural products CCOC(=O)C=CC(O)=O XLYMOEINVGRTEX-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 150000002646 long chain fatty acid esters Chemical class 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229940074369 monoethyl fumarate Drugs 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- XFHJDMUEHUHAJW-UHFFFAOYSA-N n-tert-butylprop-2-enamide Chemical compound CC(C)(C)NC(=O)C=C XFHJDMUEHUHAJW-UHFFFAOYSA-N 0.000 description 1
- 238000011580 nude mouse model Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010345 tape casting Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/725,215 US4751087A (en) | 1985-04-19 | 1985-04-19 | Transdermal nitroglycerin delivery system |
| PCT/US1986/000789 WO1986006281A1 (en) | 1985-04-19 | 1986-04-18 | Transdermal nitroglycerin delivery system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3685545D1 DE3685545D1 (de) | 1992-07-09 |
| DE3685545T2 true DE3685545T2 (de) | 1992-12-24 |
Family
ID=24913627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8686902978T Expired - Lifetime DE3685545T2 (de) | 1985-04-19 | 1986-04-18 | System zur transdermalen abgabe von nitroglycerin. |
Country Status (14)
Families Citing this family (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5422118A (en) * | 1986-11-07 | 1995-06-06 | Pure Pac, Inc. | Transdermal administration of amines with minimal irritation and high transdermal flux rate |
| US4746515A (en) * | 1987-02-26 | 1988-05-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
| JPH0696529B2 (ja) * | 1987-03-31 | 1994-11-30 | 積水化学工業株式会社 | ニトログリセリン貼付剤およびその製造方法 |
| US4906475A (en) | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
| AU630347B2 (en) * | 1988-02-26 | 1992-10-29 | Riker Laboratories, Inc. | Transdermal estradiol delivery system |
| US5223261A (en) * | 1988-02-26 | 1993-06-29 | Riker Laboratories, Inc. | Transdermal estradiol delivery system |
| US5300291A (en) * | 1988-03-04 | 1994-04-05 | Noven Pharmaceuticals, Inc. | Method and device for the release of drugs to the skin |
| US4994278A (en) * | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Breathable backing |
| US5719197A (en) * | 1988-03-04 | 1998-02-17 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
| DE3823070A1 (de) * | 1988-07-07 | 1990-02-22 | Kettelhack Riker Pharma Gmbh | Selbstklebendes heftpflaster |
| EP0364211B1 (en) * | 1988-10-11 | 1994-12-21 | Shire Holdings Ltd. | A percutaneous pharmaceutical preparation |
| US5008110A (en) * | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
| US5238944A (en) * | 1988-12-15 | 1993-08-24 | Riker Laboratories, Inc. | Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine |
| US5736553A (en) * | 1988-12-15 | 1998-04-07 | Riker Laboratories, Inc. | Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine |
| US5241925A (en) * | 1988-12-27 | 1993-09-07 | Dermamed | Apparatus and techniques for administering veterinary medicaments |
| US5332577A (en) * | 1988-12-27 | 1994-07-26 | Dermamed | Transdermal administration to humans and animals |
| US5091186A (en) * | 1989-08-15 | 1992-02-25 | Cygnus Therapeutic Systems | Biphasic transdermal drug delivery device |
| US5262165A (en) * | 1992-02-04 | 1993-11-16 | Schering Corporation | Transdermal nitroglycerin patch with penetration enhancers |
| US5324521A (en) * | 1989-12-18 | 1994-06-28 | Dermamed | Systems for transdermal administration of medicaments |
| US5204109A (en) * | 1989-12-28 | 1993-04-20 | Nitto Denko Corporation | Percutaneous gel preparation |
| DE69026361T2 (de) * | 1989-12-28 | 1996-08-14 | Nitto Denko Corp | Gelpräparat für die perkutane Verabreichung |
| US5057500A (en) * | 1990-02-12 | 1991-10-15 | Dermatologic Research Corporation | Treatment of pruritis with esters and amides |
| JP2820306B2 (ja) * | 1990-02-27 | 1998-11-05 | 積水化学工業株式会社 | 経皮吸収製剤 |
| JPH07116032B2 (ja) * | 1990-04-06 | 1995-12-13 | 積水化学工業株式会社 | ニトログリセリン貼付剤 |
| CA2039586A1 (en) * | 1990-05-02 | 1991-11-03 | Marian R. Appelt | Crosslinked pressure-sensitive adhesives tolerant of alcohol-based excipients used in transdermal delivery devices and method of preparing same |
| GB9021674D0 (en) * | 1990-10-05 | 1990-11-21 | Ethical Pharma Ltd | Transdermal device |
| US5202125A (en) * | 1990-12-10 | 1993-04-13 | Theratech, Inc. | Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes |
| US5122383A (en) * | 1991-05-17 | 1992-06-16 | Theratech, Inc. | Sorbitan esters as skin permeation enhancers |
| DE59203307D1 (de) | 1991-06-10 | 1995-09-21 | Lohmann Therapie Syst Lts | Nitroglycerin-pflaster und verfahren zu seiner herstellung. |
| US5273755A (en) * | 1991-08-23 | 1993-12-28 | Cygnus Therapeutic Systems | Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset |
| US5273756A (en) * | 1991-08-23 | 1993-12-28 | Cygnus Therapeutic Systems | Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset |
| US5234690A (en) * | 1991-08-23 | 1993-08-10 | Cygnus Therapeutic Systems | Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset |
| US5278192A (en) * | 1992-07-02 | 1994-01-11 | The Research Foundation Of State University Of New York | Method of vasodilator therapy for treating a patient with a condition |
| GB2273044B (en) * | 1992-12-02 | 1997-04-09 | Pacific Chem Co Ltd | Medicinal patches for percutaneous administration |
| US5762952A (en) * | 1993-04-27 | 1998-06-09 | Hercon Laboratories Corporation | Transdermal delivery of active drugs |
| JP2539330B2 (ja) * | 1993-05-11 | 1996-10-02 | 日東電工株式会社 | 医療用粘着剤及びこれを用いて形成された医療用外用材 |
| EP0707465A4 (en) * | 1993-07-08 | 1997-04-16 | Cygnus Therapeutic Systems | MONOLITHIC MATRIX TRANSDERMAL DELIVERY SYSTEM |
| US5385736A (en) * | 1993-07-12 | 1995-01-31 | Minnesota Mining And Manufacturing Company | Transdermal melatonin delivery system |
| US5494680A (en) * | 1993-12-08 | 1996-02-27 | Minnesota Mining And Manufacturing Company | Transdermal delivery device |
| GB2292520B (en) * | 1994-08-25 | 1998-09-02 | Univ Sheffield | Transdermal dressings for animals |
| DK0781122T3 (da) * | 1994-09-14 | 2000-10-30 | Minnesota Mining & Mfg | Matrix til transdermal lægmiddelafgivelse |
| JP3604177B2 (ja) * | 1994-09-14 | 2004-12-22 | 日東電工株式会社 | 経皮吸収製剤 |
| US5702720A (en) * | 1995-12-22 | 1997-12-30 | Minnesota Mining And Manufacturing Company | Transdermal device for the delivery of flurbiprofen |
| AU732803B2 (en) * | 1996-01-17 | 2001-05-03 | National Starch And Chemical Investment Holding Corporation | Adhesives resistant to skin-penetration enhancers |
| JP3628809B2 (ja) * | 1996-06-10 | 2005-03-16 | アルケア株式会社 | 薬剤徐放性医療用配合物及びその製造方法 |
| DE69833254T2 (de) | 1997-06-23 | 2006-11-02 | Cellegy Pharmaceuticals, Inc., Brisbane | Microdosistherapie von gefässbedingten erscheinungen durch no-donoren |
| US20040018241A1 (en) * | 1997-09-26 | 2004-01-29 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
| EP1021204B1 (en) | 1997-09-26 | 2005-12-28 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
| AU1728099A (en) * | 1997-12-22 | 1999-07-12 | Alza Corporation | Monoglyceride and ethyl palmitate permeation enhancer compositions |
| DE19818955C2 (de) * | 1998-04-28 | 2000-06-29 | Lohmann Therapie Syst Lts | Zusammensetzung, enthaltend Polyacrylat, Polyterpen, Nitroglycerin und wahlweise Polyvinylacetat |
| DE19830648A1 (de) * | 1998-07-09 | 2000-01-13 | Lohmann Therapie Syst Lts | Glyceroltrinitrathaltige Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung |
| US6160086A (en) * | 1998-07-30 | 2000-12-12 | 3M Innovative Properties Company | Process for removing impurities from polymers |
| AU768283B2 (en) | 1998-08-20 | 2003-12-04 | 3M Innovative Properties Company | Spray on bandage and drug delivery system |
| US6383511B1 (en) | 1999-10-25 | 2002-05-07 | Epicept Corporation | Local prevention or amelioration of pain from surgically closed wounds |
| AU2002232471A1 (en) * | 2000-10-31 | 2002-05-15 | Nutrition 21, Inc. | Methods and compositions for the treatment of polycystic ovary syndrome with chromium complexes |
| US6682757B1 (en) | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
| US6638981B2 (en) | 2001-08-17 | 2003-10-28 | Epicept Corporation | Topical compositions and methods for treating pain |
| CA2478065C (en) | 2002-03-08 | 2013-01-08 | Eisai Co. Ltd. | Macrocyclic compounds useful as pharmaceuticals |
| JP5065571B2 (ja) * | 2002-08-30 | 2012-11-07 | アルザ・コーポレーシヨン | エンボス加工可能で書き込み可能な多層裏地構造物 |
| KR101080026B1 (ko) * | 2003-06-24 | 2011-11-04 | 니프로 패치 가부시키가이샤 | 의료용 경피 흡수 테이프 제제용 비수성 점착제 및 의료용경피 흡수 테이프 제제 및 그 제조법 |
| DE10340428B4 (de) | 2003-09-02 | 2015-02-12 | Acino Ag | Opioides Analgetikum enthaltende transdermale Formulierung |
| US20050065062A1 (en) * | 2003-09-24 | 2005-03-24 | 3M Innovative Properties Company | Method of formulating a pharmaceutical composition |
| WO2005067910A1 (ja) * | 2004-01-20 | 2005-07-28 | Saitama Daiichi Pharmaceutical Co., Ltd. | ツロブテロール貼付剤 |
| EP1773444B1 (en) | 2004-06-10 | 2017-09-20 | 3M Innovative Properties Company | Patch application device and kit |
| US20060029654A1 (en) * | 2004-08-04 | 2006-02-09 | Cassel R D | Analgesic patch for sports injury rehabilitation medicine and method to alleviate pain |
| EP1802665B1 (en) * | 2004-10-19 | 2009-08-05 | 3M Innovative Properties Company | Method for the manufacture of pressure sensitive adhesives |
| EP1829562B1 (en) | 2004-12-15 | 2013-04-03 | Nipro Patch Co., Ltd. | Medical tape preparation |
| US8080560B2 (en) * | 2004-12-17 | 2011-12-20 | 3M Innovative Properties Company | Immune response modifier formulations containing oleic acid and methods |
| US20060223786A1 (en) * | 2005-04-01 | 2006-10-05 | Smith David J | Transdermal pain control method and device |
| GT200600396A (es) * | 2005-09-07 | 2007-04-23 | Dispositivos para la aplicacion de medicamentos transdermicos conteniendo o-desmetil venlafaxina (odv) o sus sales | |
| US8889154B2 (en) | 2005-09-15 | 2014-11-18 | Medicis Pharmaceutical Corporation | Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation |
| US20070259026A1 (en) * | 2006-04-20 | 2007-11-08 | Robert Ang | Vasodialating dressing for use with intravenous catheters |
| US20070248657A1 (en) * | 2006-04-25 | 2007-10-25 | Smith David J | Multi-compartment transdermal pain control device |
| WO2008010963A2 (en) * | 2006-07-18 | 2008-01-24 | 3M Innovative Properties Company | Immune response modifier formulations |
| CA2659733A1 (en) * | 2006-07-31 | 2008-02-07 | 3M Innovative Properties Company | Sterilized topical compositions of 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine |
| EP3176169A1 (en) * | 2007-01-31 | 2017-06-07 | Chongxi Yu | Positively charged water-soluble prodrugs of 1h-imidazo[4,5-c]quinolin-4-amines and related compounds with very high skin penetration rates |
| DE102007021549A1 (de) | 2007-05-08 | 2008-11-13 | Novosis Ag | Transdermales therapeutisches System enthaltend mindestens zwei Opioide |
| US20090304776A1 (en) * | 2008-06-06 | 2009-12-10 | Totada Shantha | Transmucosal delivery of therapeutic agents and methods of use thereof |
| US7883487B2 (en) * | 2008-06-16 | 2011-02-08 | Shantha Totada R | Transdermal local anesthetic patch with injection port |
| US20100160368A1 (en) | 2008-08-18 | 2010-06-24 | Gregory Jefferson J | Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy |
| US20100221313A1 (en) * | 2008-12-01 | 2010-09-02 | Innovative Pharmaceuticals, Llc | Transdermal reservoir patch |
| HUE041944T2 (hu) | 2008-12-19 | 2019-06-28 | Medicis Pharmaceutical Corp | Alacsony dózisú imiquimod készítmények és rövid adagolási módszer aktinikus keratózis kezelésére |
| BR112012000797A2 (pt) * | 2009-07-13 | 2016-08-09 | Medicis Pharmaceutical Corp | formulações de imiquimode de intensidade de dosagem inferior e regimes curtos de dosagem para tratamento de verrugas genitais e perianais |
| WO2011027786A1 (ja) * | 2009-09-07 | 2011-03-10 | ニプロパッチ株式会社 | 経皮吸収型製剤 |
| DK2584900T3 (en) | 2010-06-25 | 2019-04-01 | Medicis Pharmaceutical Corp | Combination therapy with cryosurgery and low-dose imiquimod for the treatment of actinic keratosis |
| WO2013090353A1 (en) | 2011-12-16 | 2013-06-20 | 3M Innovative Properties Company | Foldable adhesive composite dressing |
| WO2013096026A1 (en) | 2011-12-21 | 2013-06-27 | 3M Innovative Properties Company | Transdermal adhesive patch assembly with removable microneedle array and method of using same |
| AU2012355678B2 (en) | 2011-12-21 | 2015-04-02 | Kindeva Drug Delivery L.P. | Adhesive patch assembly with overlay liner and system and method for making same |
| US20140004204A1 (en) * | 2012-06-29 | 2014-01-02 | University Of South Florida | Biocompatible polyacrylate compositions and methods of use |
| EP2906284B8 (en) | 2012-10-10 | 2021-01-20 | Kindeva Drug Delivery L.P. | Force-controlled applicator for applying a microneedle device to skin |
| WO2014078545A1 (en) | 2012-11-16 | 2014-05-22 | 3M Innovative Properties Company | Force-controlled applicator for applying a microneedle device to skin |
| WO2014153447A2 (en) | 2013-03-22 | 2014-09-25 | 3M Innovative Properties Company | Microneedle applicator comprising a counter assembly |
| KR102274902B1 (ko) | 2013-05-31 | 2021-07-07 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 마이크로니들 주사 및 주입 장치 및 그의 사용 방법 |
| EP3381500B1 (en) | 2013-05-31 | 2020-11-04 | 3M Innovative Properties Co. | Microneedle injection apparatus comprising an inverted actuator |
| EP3003458B1 (en) | 2013-05-31 | 2019-12-04 | 3M Innovative Properties Company | Microneedle injection apparatus comprising a dual cover |
| EP3033056B1 (en) | 2013-08-12 | 2020-01-15 | 3M Innovative Properties Company | Peptides for enhancing transdermal delivery |
| EP3020398A1 (en) | 2014-11-17 | 2016-05-18 | Nitto Denko Corporation | Compounds and formulations for reducing scarring |
| CN108601749A (zh) | 2016-02-05 | 2018-09-28 | 3M创新有限公司 | 具有氟代硅氧烷剥离衬件的透皮药物递送体系 |
| EP3287462A1 (en) | 2016-08-25 | 2018-02-28 | Nitto Denko Corporation | Isosorbide derivatives to treat bacterial biofilms |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
| DE2528516A1 (de) * | 1974-07-05 | 1976-01-22 | Sandoz Ag | Neue galenische zubereitung |
| DE2920500A1 (de) * | 1979-05-21 | 1980-11-27 | Boehringer Sohn Ingelheim | Pharmazeutische zubereitung in form eines polyacrylatfilmes |
| JPS5777617A (en) * | 1980-10-20 | 1982-05-15 | Nichiban Co Ltd | Plaster for cardiac disease |
| JPS5843368B2 (ja) * | 1980-10-30 | 1983-09-27 | 日東電工株式会社 | 消炎鎮痛貼付剤 |
| JPS6059207B2 (ja) * | 1981-03-13 | 1985-12-24 | 日東電工株式会社 | 複合製剤の製法 |
| JPS58913A (ja) * | 1981-06-26 | 1983-01-06 | Nitto Electric Ind Co Ltd | 局所系医薬製剤 |
| US4542013A (en) * | 1981-07-08 | 1985-09-17 | Key Pharmaceuticals, Inc. | Trinitroglycerol sustained release vehicles and preparation therefrom |
| US4585452A (en) * | 1983-04-12 | 1986-04-29 | Key Pharmaceuticals, Inc. | Transdermal systemic dosage forms |
| JPS59199628A (ja) * | 1983-04-25 | 1984-11-12 | Sekisui Chem Co Ltd | 貼付剤 |
| US4588580B2 (en) * | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
| EP0190262B1 (en) * | 1984-07-24 | 1990-12-27 | Key Pharmaceuticals, Inc. | Adhesive transdermal dosage layer |
-
1985
- 1985-04-19 US US06/725,215 patent/US4751087A/en not_active Expired - Lifetime
-
1986
- 1986-04-09 NZ NZ215746A patent/NZ215746A/xx unknown
- 1986-04-16 IL IL78527A patent/IL78527A/xx not_active IP Right Cessation
- 1986-04-18 DE DE8686902978T patent/DE3685545T2/de not_active Expired - Lifetime
- 1986-04-18 CA CA000507068A patent/CA1273871A/en not_active Expired - Lifetime
- 1986-04-18 ES ES554144A patent/ES8802370A1/es not_active Expired
- 1986-04-18 ZA ZA862945A patent/ZA862945B/xx unknown
- 1986-04-18 AU AU57725/86A patent/AU593810B2/en not_active Expired
- 1986-04-18 EP EP86902978A patent/EP0219539B1/en not_active Expired - Lifetime
- 1986-04-18 AT AT86902978T patent/ATE76736T1/de not_active IP Right Cessation
- 1986-04-18 IE IE103586A patent/IE59725B1/en not_active IP Right Cessation
- 1986-04-18 WO PCT/US1986/000789 patent/WO1986006281A1/en active IP Right Grant
- 1986-04-18 JP JP61502454A patent/JP2588180B2/ja not_active Expired - Lifetime
-
1991
- 1991-12-19 CZ CS913905A patent/CZ390591A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US4751087A (en) | 1988-06-14 |
| NZ215746A (en) | 1989-08-29 |
| US4751087B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-03-02 |
| JPS62502965A (ja) | 1987-11-26 |
| IE59725B1 (en) | 1994-03-23 |
| DE3685545D1 (de) | 1992-07-09 |
| WO1986006281A1 (en) | 1986-11-06 |
| IE861035L (en) | 1986-10-19 |
| IL78527A (en) | 1991-07-18 |
| AU5772586A (en) | 1986-11-18 |
| ZA862945B (en) | 1987-12-30 |
| EP0219539B1 (en) | 1992-06-03 |
| AU593810B2 (en) | 1990-02-22 |
| EP0219539A1 (en) | 1987-04-29 |
| IL78527A0 (en) | 1986-08-31 |
| CZ390591A3 (en) | 1993-07-14 |
| ATE76736T1 (de) | 1992-06-15 |
| JP2588180B2 (ja) | 1997-03-05 |
| ES554144A0 (es) | 1988-05-16 |
| ES8802370A1 (es) | 1988-05-16 |
| CA1273871A (en) | 1990-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3685545T2 (de) | System zur transdermalen abgabe von nitroglycerin. | |
| DE68917292T2 (de) | Transdermales estradiol als therapeutisches sytem. | |
| DE3111550C2 (de) | Antiphlogistisches analgetisches Pflaster | |
| DE69218932T2 (de) | Transdermale therapeutische Formulierung | |
| DE69010076T2 (de) | Transdermales therapeutisches Mittel. | |
| DE68920109T2 (de) | Arzneimittelpräparat für perkutane Absorption. | |
| DE69514178T2 (de) | Isosorbiddinitrat enthaltendes Präparat zur perkutanen Resorption | |
| EP0439180B1 (de) | Transdermales therapeutisches System mit dem Wirkstoff Tulobuterol | |
| DE69431209T2 (de) | Transdermale prostaglandin-zusammensetzung | |
| DE69715049T2 (de) | Tranilast enthaltendes externum und verfahren zu dessen herstellung | |
| EP0186019B1 (de) | Wirkstoffpflaster | |
| DE4241874C2 (de) | Medizinisches Pflaster für die perkutane Verabreichung des Wirkstoffs Ketoprofen | |
| DE69108683T2 (de) | Zubereitung zur transdermalen Verabreichung von Arzneimitteln. | |
| DE69020875T2 (de) | Oestrogenhaltiges Gelpräparat. | |
| DE69320096T2 (de) | Verabreichungssystem für Östradiol | |
| DE69508342T2 (de) | Zusammensetzung zur perkutan Absorption | |
| EP0020905A1 (de) | Pharmazeutische Zubereitung in Form eines Polyacrylatfilmes und deren Herstellung | |
| CH672598A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE3880212T2 (de) | Pharmazeutische zusammensetzung zur hautabsorption und hautabsorptionsverstaerkung von medikamenten. | |
| DE68911499T2 (de) | Topisch anzuwendende Zubereitungen und Systeme zur transdermalen Verabreichung enthaltend 1-Isobutyl-1H-imidazo[4,5-c]chinolin-4-amine. | |
| EP0305726B1 (de) | Transdermales therapeutisches System | |
| DE3587048T2 (de) | Pharmazeutische praeparate. | |
| EP0518113A1 (de) | Nitroglycerin-Pflaster und Verfahren zu seiner Herstellung | |
| EP1303267B1 (de) | Dermales applikationssystem für aminolävulinsäure | |
| DE69010317T2 (de) | Acrylgel und seine Herstellung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |